Article: The need for evolution in pharmacovigilance

30 March 2020

Pharmafocus published an interview with our Director, Saad Shakir, in its March issue, focusing on the need for pharmacovigilance to evolve in order to handle the challenges posed by scientific innovation and political upheaval. While we have seen a shift to more proactive pharmacovigilance, we will need further modification of existing methods, especially for biologic therapies where patients tend to be sicker, taking many medicines and suffering concurrent illnesses.

Read the article in full here: https://en.calameo.com/read/0061133857c3d689fd31b?page=16